» Articles » PMID: 31576110

Effects of Loratadine, a Histamine H Receptor Antagonist, on the Skeletal System of Young Male Rats

Overview
Specialty Pharmacology
Date 2019 Oct 3
PMID 31576110
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Histamine H receptor antagonists are widely used in the treatment of allergic diseases. H receptors are expressed on bone cells and histamine takes part in regulation of bone metabolism. Loratadine is often prescribed to children.

Purpose: The aim of the present study was to investigate the effects of loratadine on the skeletal system of young rats.

Material And Methods: Loratadine (0.5, 5, and 50 mg/kg p.o. daily) was administered for 4 weeks to male Wistar rats, 6-week-old at the start of the experiment. Bone mass, mass of bone mineral, calcium, and phosphorus content in the bone mineral of the tibia, femur, and L-4 vertebra, histomorphometric parameters of the femur, mechanical properties of the proximal tibial metaphysis, femoral diaphysis and femoral neck, and serum levels of bone turnover markers were examined.

Results: Loratadine at 0.5 and 5 mg/kg did not significantly affect the skeletal system of young rats. At 50 mg/kg, loratadine decreased the femoral length, increased content of calcium and phosphorus in the bone mineral of the vertebra, and tended to improve mechanical properties of the tibial metaphysis.

Conclusion: High-dose loratadine slightly but significantly affected development of the skeletal system in rapidly growing rats.

Citing Articles

Repurposing of H-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software.

Specht T, Seifert R Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(5):2995-3018.

PMID: 37870580 PMC: 11074024. DOI: 10.1007/s00210-023-02796-9.


Effect of Administration of Azithromycin and/or Probiotic Bacteria on Bones of Estrogen-Deficient Rats.

Cegiela U, Londzin P, Janas A, Pytlik M, Folwarczna J Pharmaceuticals (Basel). 2022; 15(8).

PMID: 35893739 PMC: 9331654. DOI: 10.3390/ph15080915.


Gluing Living Bone Using a Biomimetic Bioadhesive: From Initial Cut to Final Healing.

Procter P, Hulsart-Billstrom G, Alves A, Pujari-Palmer M, Wenner D, Insley G Front Bioeng Biotechnol. 2021; 9:728042.

PMID: 34820360 PMC: 8606677. DOI: 10.3389/fbioe.2021.728042.


Long-Term Administration of Abacavir and Etravirine Impairs Semen Quality and Alters Redox System and Bone Metabolism in Growing Male Wistar Rats.

Matuszewska A, Nowak B, Nizanski W, Eberhardt M, Domrazek K, Nikodem A Oxid Med Cell Longev. 2021; 2021:5596090.

PMID: 34373766 PMC: 8349296. DOI: 10.1155/2021/5596090.


Effects of Histamine Receptor Antagonist Cetirizine on Orthodontic Tooth Movement.

Sperl G, Gattner J, Deschner J, Wolf M, Proff P, Schroder A Biomedicines. 2020; 8(12).

PMID: 33302395 PMC: 7762581. DOI: 10.3390/biomedicines8120583.


References
1.
Williams K . Update on Bone Health in Pediatric Chronic Disease. Endocrinol Metab Clin North Am. 2016; 45(2):433-41. PMC: 5278623. DOI: 10.1016/j.ecl.2016.01.009. View

2.
Biosse-Duplan M, Baroukh B, Dy M, de Vernejoul M, Saffar J . Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol. 2009; 174(4):1426-34. PMC: 2671373. DOI: 10.2353/ajpath.2009.080871. View

3.
Turner C, Burr D . Basic biomechanical measurements of bone: a tutorial. Bone. 1993; 14(4):595-608. DOI: 10.1016/8756-3282(93)90081-k. View

4.
Degboe Y, Eischen M, Nigon D, Apoil P, Mailhol C, Tournier E . Prevalence and risk factors for fragility fracture in systemic mastocytosis. Bone. 2017; 105:219-225. DOI: 10.1016/j.bone.2017.09.005. View

5.
Vestergaard P, Rejnmark L, Mosekilde L . Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int. 2006; 79(2):76-83. DOI: 10.1007/s00223-006-0021-7. View